Home Cart 0 Sign in  
X

[ CAS No. 4214-73-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 4214-73-7
Chemical Structure| 4214-73-7
Chemical Structure| 4214-73-7
Structure of 4214-73-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4214-73-7 ]

Related Doc. of [ 4214-73-7 ]

Alternatived Products of [ 4214-73-7 ]

Product Details of [ 4214-73-7 ]

CAS No. :4214-73-7 MDL No. :MFCD00128902
Formula : C6H5N3 Boiling Point : -
Linear Structure Formula :- InChI Key :KDVBYUUGYXUXNL-UHFFFAOYSA-N
M.W : 119.12 Pubchem ID :818260
Synonyms :

Calculated chemistry of [ 4214-73-7 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.36
TPSA : 62.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.87 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.92
Log Po/w (XLOGP3) : 0.22
Log Po/w (WLOGP) : 0.54
Log Po/w (MLOGP) : -0.43
Log Po/w (SILICOS-IT) : 0.62
Consensus Log Po/w : 0.37

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.21
Solubility : 7.34 mg/ml ; 0.0616 mol/l
Class : Very soluble
Log S (Ali) : -1.1
Solubility : 9.55 mg/ml ; 0.0801 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.7
Solubility : 2.37 mg/ml ; 0.0199 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.63

Safety of [ 4214-73-7 ]

Signal Word:Danger Class:9
Precautionary Statements:P261-P273-P301+P310-P311-P501 UN#:3077
Hazard Statements:H301-H331-H410 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 4214-73-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4214-73-7 ]
  • Downstream synthetic route of [ 4214-73-7 ]

[ 4214-73-7 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 4214-73-7 ]
  • [ 69879-22-7 ]
YieldReaction ConditionsOperation in experiment
73.16% With lithium aluminium tetrahydride In tetrahydrofuran for 1.5 h; To a solution of compound 53.9 (10 g, 83.95 mmol, 1 eq) in THF (150 mL) wasadded LAH (6.37 g, 167.90 mmol, 2 eq) at 0°C. The mixture was stirred at 0°C for 1.5 hours.The reaction mixture was quenched by addition saturated sodium sulfate at 0 °C and added100 ml H20 then extracted with ethyl acetate (100 mL x 3). The combined organic layerswere washed with saturated brines (30 mL x 1), dried over anhydrous sodium sulfate, filteredand concentrated under reduced pressure to give the product compound 53.8 (7.50 g, 61.42mmol, 73.16percent yield) as a yellow oil. LCMS (ESI): m/z: [M + H] called for C6H6N20: 123;found 123; RT=0.099 mm.
30% With diisobutylaluminium hydride In tetrahydrofuran; hexane at 0℃; 4.1.1
Synthesis of 6-aminopyridine-3-carboxaldehyde
A 1M solution of diisobutylaluminum hydride (DIBAL) in hexane (10 mL) was added to a solution of 6-amino-5-cyanopyridine (10 mmol) in dry THF (50 mL) cooled at 0 °C.
The ice-bath was removed, and additional 7.1 mL of a 1M solution of DIBAL in hexane were added in two successive portions.
After stirring for additional 30 min, the reaction was quenched by the dropwise addition of dry MeOH (15 mL).
The mixture was partitioned between 100 mL of AcOEt and 70 mL of 2N HCl.
The aqueous layer was treated with 75 mL of 2N NaOH and extracted with AcOEt.
The organic layers were washed with brine, dried over anhydrous Na2SO4, filtered and evaporated to dryness.
The residue was purified by column chromatography on silica gel eluting with CHCl3/AcOEt 1:4. Yield: 30percent, mp = 174-175 °C. IR (KBr): 3366, 3121, 1659 cm-1. 1H NMR (CD3OD, 400 MHz): δ (ppm) 9.67 (s, 1H, CHO), 8.41 (d, 1H, H2, J2-4 = 1.6 Hz), 7.87 (dd, 1H, H4, J4-5 = 8.8 Hz, J2-4 = 1.6 Hz), 6.63 (d, 1H, H5, J4-5 = 8.8 Hz), 3.31 (s, 2H, NH2).
13C NMR (CDCl3, 100 MHz): δ (ppm) 191.15, 164.46, 155.78, 137.39, 123.92, 109.99.
Reference: [1] Patent: WO2018/209132, 2018, A1, . Location in patent: Paragraph 0458; 0489
[2] European Journal of Medicinal Chemistry, 2016, vol. 117, p. 292 - 300
[3] Patent: US2009/143420, 2009, A1, . Location in patent: Page/Page column 7
[4] Patent: EP1724263, 2006, A1, . Location in patent: Page/Page column 55
[5] Patent: EP3305785, 2018, A1, . Location in patent: Paragraph 0177; 0178
  • 2
  • [ 4214-73-7 ]
  • [ 468068-28-2 ]
  • [ 329-89-5 ]
YieldReaction ConditionsOperation in experiment
22% With hydroxylamine hydrochloride; sodium carbonate In ethanol; water for 6 h; Heating / reflux A stirred mixture of commercially available 2-amino-5-cyano-pyridine [CAS-No. 4214-73-7] (5.0 g, 42 mmol), hydroxylamine hydrochloride (17.5 g, 0.25 mol) and sodium carbonate (31.1 g, 0.29 mol) in water (95 mL) and ethanol (21 mL) was heated under reflux conditions for 6 h. The reaction mixture was poured into water (150 mL) and extracted with ethyl acetate (4.x.100 mL). The combined organic layers were washed with brine (150 mL), dried (MgSO4) and evaporated.The crude product was purified by column chromatography on silica gel (ethyl acetate/MeOH/NH4OH 4:1:0.5) and crystallization (ethyl acetate/MeOH/hexane) to yield 6-amino-nicotinamide (1.39 g) and the title compound (1.42 g, 22percent) as an off-white solid. MS (EI) 152.1 [(M)+]; mp 300° C.
Reference: [1] Patent: US2007/232583, 2007, A1, . Location in patent: Page/Page column 43
  • 3
  • [ 4214-73-7 ]
  • [ 329-89-5 ]
YieldReaction ConditionsOperation in experiment
22% With hydroxylamine hydrochloride; sodium carbonate In ethanol; water for 6 h; Heating / reflux Example B.4 6-Amino-N-hydroxy-nicotinamidine; A stirred mixture of commercially available 2-amino-5-cyano-pyridine [CAS-No. 4214-73-71 (5.0 g, 42 mmol), hydroxylamine hydrochloride (17.5 g, 0.25 mol) and sodium carbonate (31.1 g, 0.29 mol) in water (95 ml) and ethanol (21 ml) was heated under reflux conditions for 6h. The reaction mixture was poured into water (150 ml) and extracted with ethyl acetate (4.x.100 ml). The combined organic layers were washed with brine (150 ml), dried (MgSO4) and evaporated. The crude product was purified by column chromatography on silica gel (ethyl acetate/MeOH/NH4OH 4:1:0.5) and crystallization (ethyl acetate/MeOH/hexane) to yield 6-amino-nicotinamide (1.39 g) and the title compound (1.42 g, 22percent) as an off-white solid. MS (EI) 152.1 [(M)+]; mp 300° C.
Reference: [1] Patent: US2007/72879, 2007, A1, . Location in patent: Page/Page column 14
  • 4
  • [ 4214-73-7 ]
  • [ 329-89-5 ]
Reference: [1] Journal of the American Chemical Society, 1947, vol. 69, p. 1147,1148
[2] Journal of the American Chemical Society, 1944, vol. 66, p. 1479,1482
[3] Chemicke Listy, 1952, vol. 46, p. 770[4] Chem.Abstr., 1953, p. 11191
  • 5
  • [ 52334-81-3 ]
  • [ 4214-73-7 ]
  • [ 74784-70-6 ]
Reference: [1] Heterocycles, 1984, vol. 22, # 1, p. 117 - 124
  • 6
  • [ 4214-73-7 ]
  • [ 477871-32-2 ]
YieldReaction ConditionsOperation in experiment
65% at 20℃; for 2 h; Example 36; 8- [ (3-Methyl-butylamino)-methyl]-10, 11-dihydro-5-oxa-4-aza- dibenzo [a, d] cycloheptene-2-carboxylic acid amide; Step 1; 6-Amino-5-bromo-nicotinonitrile; To a solution of 6-Amino-nicotinonitrile (102 mg, 0.86 mmol) in AcOH (2 mL) add a solution of Br2 l. OM in AcOH (0.86 mmol). Stir the mixture at room temperature for 2 hours. Eliminate the solvent. Purify by flash chromatography on silica gel (eluent: hexane/EtOAc 3/1) to afford the title compound (110 mg, 65percent). 'H-NMR (DMSO, 300 MHz): 8.26 (d, 1 H, J= 2.0 Hz), 8.10 (d, 1H, J= 2.0 Hz), 7.24 (bs 2H). MS (APCI Neg) : 196,198
11.2 g With N-Bromosuccinimide In tetrahydrofuran at 20℃; for 1 h; Inert atmosphere; Schlenk technique To a well stirred solution of 6-aminopyridine-3-carbonitrile (8.0 g, 67.15 mmol) in tetrahydrofuran (100 ml) was added N-bromosuccinimide (17.92 g, 100.72 mmol) and stirred at room temperature for 1 h. The reaction mixture was diluted with water (100 ml) and extracted with ethyl acetate (2 x 200 ml). The combined organic layers were washed with 2N sodium hydroxide solution (100 ml) and brine (100 ml). The mixture was dried over anhydrous sodium sulphate and concentrated under reduced pressure. The residue obtained was crystallized from a mixture of diethyl ether and n-pentane to yield 11.2 g of product as a white solid.
8.2 g at 10 - 35℃; for 72 h; Cooling with ice To a solution of 6-aminonicotinonitrile (5.0 g) in acetic acid (50 mL) was added bromine (4.3 mL) under ice-cooling.
The reaction mixture was stirred at room temperature for 3 days, and the precipitate was collected by filtration.
The obtained solid was suspended in ethyl acetate and IPE, and collected by filtration to give the title compound (8.2 g).
1H NMR (300 MHz, DMSO-d6) δ 7.31 (2H, brs), 8.19 (1H, d, J 1.9 Hz), 8.36 (1H, d, J=1.9 Hz).
15.8 g With bromine In chloroform; water at 0 - 20℃; for 2.5 h; Reference Example 341
2-amino-3-bromo-5-cyanopyridine
To a chloroform solution (160 mL) of 2-amino-5-cyanopyridine (10.0 g) were added bromine (4.50 mL) and water (40.0 mL) at 0°C, and the reaction mixture was stirred at room temperature for 2.5 h
Aqueous sodium thiosulfate solution and aqueous sodium hydrogen carbonate solution were added and the mixture was extracted twice with chloroform.
The organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated to give the title compound (15.8 g).
MS(ESI)m/z; 198,200[M+H]+

Reference: [1] Patent: WO2005/90337, 2005, A1, . Location in patent: Page/Page column 42-43
[2] Patent: WO2008/60907, 2008, A2, . Location in patent: Page/Page column 38
[3] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 9, p. 2073 - 2078
[4] Patent: US2015/266872, 2015, A1, . Location in patent: Paragraph 0783; 0784
[5] Patent: EP3372601, 2018, A1, . Location in patent: Paragraph 0743; 0744
  • 7
  • [ 4214-73-7 ]
  • [ 943845-23-6 ]
Reference: [1] Patent: WO2011/79804, 2011, A1,
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 18, p. 7577 - 7589
  • 8
  • [ 4214-73-7 ]
  • [ 1187322-51-5 ]
YieldReaction ConditionsOperation in experiment
6.6 g
Stage #1: With silver trifluoroacetate In 1,2-dichloro-ethane for 5 h; Reflux
Stage #2: With iodine In 1,2-dichloro-ethane for 18 h; Reflux
Synthesis of 6-amino-5-iodonicotinonitrile
6-Amino-3-pyridinecarbonitrile (10.0 g, 0.081 mol), silver trifluoroacetate (25.5 g, 0.115 mol) and 160 ml of 1,2-dichloroethane are combined in a flask and heated under reflux for 5 h.
Iodine (29.5 g, 0.116 mol) is added, and the mixture is heated for a further 18 h.
After cooling, the mixture is filtered and partitioned between water and dichloroethane.
Organic and aqueous phase are filtered through Celite.
The aqueous phase is extracted to exhaustion, and the combined organic phases are combined, dried and evaporated.
The residue is dissolved in ethyl acetate and washed with sodium thiosulfate solution.
Removal of the solvent gives 6.6 g of yellowish crystals product.
These are reacted further without further purification; HPLC: 2.57 min; LCMS: 246 [M+H]+.
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 3, p. 1160 - 1170
[2] Patent: US2015/218155, 2015, A1, . Location in patent: Paragraph 0300
[3] Patent: WO2009/112139, 2009, A1, . Location in patent: Page/Page column 25
  • 9
  • [ 4214-73-7 ]
  • [ 943894-99-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 18, p. 7577 - 7589
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4214-73-7 ]

Amines

Chemical Structure| 183428-91-3

[ 183428-91-3 ]

2-Amino-3-methyl-5-cyanopyridine

Similarity: 0.92

Chemical Structure| 261715-36-0

[ 261715-36-0 ]

6-(Methylamino)nicotinonitrile

Similarity: 0.90

Chemical Structure| 38076-78-7

[ 38076-78-7 ]

2-Amino-5-methylnicotinonitrile

Similarity: 0.83

Chemical Structure| 769-27-7

[ 769-27-7 ]

6-Amino-2,4-dimethylnicotinonitrile

Similarity: 0.82

Chemical Structure| 57963-11-8

[ 57963-11-8 ]

4,5-Dimethylpyridin-2-amine

Similarity: 0.81

Nitriles

Chemical Structure| 183428-91-3

[ 183428-91-3 ]

2-Amino-3-methyl-5-cyanopyridine

Similarity: 0.92

Chemical Structure| 261715-36-0

[ 261715-36-0 ]

6-(Methylamino)nicotinonitrile

Similarity: 0.90

Chemical Structure| 38076-78-7

[ 38076-78-7 ]

2-Amino-5-methylnicotinonitrile

Similarity: 0.83

Chemical Structure| 769-27-7

[ 769-27-7 ]

6-Amino-2,4-dimethylnicotinonitrile

Similarity: 0.82

Chemical Structure| 100-54-9

[ 100-54-9 ]

3-Cyanopyridine

Similarity: 0.80

Related Parent Nucleus of
[ 4214-73-7 ]

Pyridines

Chemical Structure| 183428-91-3

[ 183428-91-3 ]

2-Amino-3-methyl-5-cyanopyridine

Similarity: 0.92

Chemical Structure| 261715-36-0

[ 261715-36-0 ]

6-(Methylamino)nicotinonitrile

Similarity: 0.90

Chemical Structure| 38076-78-7

[ 38076-78-7 ]

2-Amino-5-methylnicotinonitrile

Similarity: 0.83

Chemical Structure| 769-27-7

[ 769-27-7 ]

6-Amino-2,4-dimethylnicotinonitrile

Similarity: 0.82

Chemical Structure| 57963-11-8

[ 57963-11-8 ]

4,5-Dimethylpyridin-2-amine

Similarity: 0.81